Grants Reporting

The following table details all grants that Cancer Australia has funded since 1 January 2009.

Agency / Program Title / Program Component
(if applicable) / Recipient / Purpose / Value / Date of Effect / Grant Term (months) / Grant Funding Location / Postcode /
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / Cancer Council Victoria / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: A web-based intervention to reduce distress and improve quality of life among younger women with breast cancer: A RCT. App562002. CA-A0809/05 / $109,937.18 / 15/12/2008 / 53 / Carlton / 3053
Cancer Australia / Priority-driven Collaborative Cancer Research Scheme / Queensland Institute of Medical Research / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Towards new screening tests for oesophageal adenocarcinoma Appl ID: 552449 / $512,325 / 01/01/2009 / 59 / Herston QLD / 4006
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / University of Newcastle / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Targeting p53 isoforms, Δ40p53 and p53β, to promote chemo-sensitivity in human melanoma. App569284. CA-A0809/49 / $20,625 / 04/01/2009 / 12 / Callaghan / 2308
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / Queensland Health / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Phase II Efficacy Study of Chemo-Radiotherapy in PET Staged II-III Merkel Cell Carcinoma of the Skin. App551200. CA-A0809/06 / $101,750 / 13/01/2009 / 72 / Woolloongabba / 4102
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / University of Sydney / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Psychological morbidity, unmet needs, quality of life and patterns of care in migrant cancer patients: The first year. App571009. CA-A0809/37 / $20,229.83 / 14/01/2009 / 12 / Sydney / 2006
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / The University of Wollongong / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: In vivo assessment of small molecule uPA-directed prodrugs for the treatment of malignant disease. App573432. CA-A0809/09 / $20,556.25 / 14/01/2009 / 25 / Wollongong / 2522
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / University of Sydney / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: The role of intraprostatic glucocorticoid action in prostate physiology and pathology. App571311. CA-A0809/10 / $20,229.83 / 14/01/2009 / 12 / Sydney / 2006
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / Queensland Institute of Medical Research / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Identification of candidate tumour suppressor genes inactivated by promoter methylation in melanoma cell lines. App552466. CA-A0809/25 / $20,556.25 / 20/01/2009 / 12 / Herston / 4006
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / Queensland Institute of Medical Research / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Response to chemotherapy in ovarian cancer. App552481. CA-A0809/22 / $625,625 / 20/01/2009 / 39 / Herston / 4006
Cancer Australia / Support for Cancer Clinical Trials Program and Boost Cancer Research Program / Primary Care Collaborative Clinical trials Group (PC4TG) through University of Western Australia / Support for Cancer Clinical Trials Program - CA-A0910/16 / $311,230.70 / 27/01/2009 / 17 / University of WA, WA / 6009
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / Macquarie University / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Evaluation of an online decision aid for women with breast cancer considering reconstructive surgery. App543400. CA-A0809/29 / $103,803.34 / 30/01/2009 / 60 / North Ryde / 2109
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / University of Melbourne / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: The Renin Angiotensin System – a Novel Target in the Treatment of Colorectal Liver Metastases. App566536. CA-A0809/47 / $20,363.20 / 30/01/2009 / 18 / Parkville / 3010
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / University of Melbourne / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Overcoming chemo-resistance in leukaemia: application of Vorinostat and ABT-737 to a new in vivo model of CLL. App566746. CA-A0809/46 / $20,350 / 30/01/2009 / 12 / Parkville / 3010
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / University of Melbourne / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Characterisation of the kConFab BRCAX cohort for selected breast cancer susceptibility loci and effect on cancer risk. App566791. CA-A0809/44 / $527,107.90 / 30/01/2009 / 71 / Parkville / 3010
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / University of Melbourne / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: A randomised trial of stereotactic vs conventional radiotherapy for inoperable early stage non-small cell lung cancer. App566813. CA-A0809/45 / $286,000 / 30/01/2009 / 59 / Parkville / 3010
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / University of Melbourne / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Methylation in ductal carcinoma in situ. App566882. CA-A0809/43 / $294,398.69 / 30/01/2009 / 48 / Parkville / 3010
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / University of Melbourne / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Characterisation of a tumour-associated PIK3CA mutation using a novel mouse model. App566974. CA-A0809/42 / $20,625 / 30/01/2009 / 12 / Parkville / 3010
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / University of Melbourne / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Reversing the debilitating effects of radiotherapy-induced damage in juvenile brain. App566976. CA-A0809/41 / $20,625 / 30/01/2009 / 12 / Parkville / 3010
Cancer Australia / Support for Cancer Clinical Trials Program / Australian and New Zealand Children’s Haematology/Oncology Group (ANZCHOG) / Support for Cancer Clinical Trials Program - CA-A00809/19 / $770,880.00 / 30/01/2009 / 18 / Parkville / 3052
Cancer Australia / Support for Cancer Clinical Trials Program / Australasian Sarcoma Study Group (ASSG) through University of Melbourne / Support for Cancer Clinical Trials Program - CA-A0809/18 / $760,839.20 / 30/01/2009 / 18 / University of Melbourne, VIC / 3010
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / Garvan Institute of Medical Research / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: DNA methylation alterations as detection markers for early ovarian cancer. App535957. CA-A0809/28 / $639,375 / 02/02/2009 / 36 / Darlinghurst / 2010
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / University of NSW / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Role of Heat Shock Proteins in the Stromal Reaction of Pancreatic Cancer. App568851. CA-A0809/27 / $20,350 / 02/02/2009 / 12 / Sydney / 2052
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / Melbourne Health / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Resveratrol in the chemoprevention of colorectal neoplasia. App544307. CA-A0809/39 / $633,325 / 03/02/2009 / 60 / Parkville / 3050
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / University of Melbourne / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: A nurse led psychosocial intervention with peer support to reduce psychosocial needs in women with gynaecological cancer. App566942. CA-A0809/40 / $127,930 / 03/02/2009 / 24 / Parkville / 3010
Cancer Australia / Support for Cancer Clinical Trials Program / Cooperative Trials Group for Neuro-Oncology (COGNO) through University of Sydney / Support for Cancer Clinical Trials Program - CA-A0809/17 / $364,455.30 / 03/02/2009 / 17 / University of Sydney, NSW / 2006
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / Prince Charles Hospital / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Individualising treatment for mesothelioma. App550600. CA-A0809/48 / $384,450 / 04/02/2009 / 50 / Chermside / 4032
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / University of Newcastle / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Blood cancer survivors and support persons: A national survey of rural/urban unmet needs and psychological disturbance. App569290. CA-A0809/50 / $285,360.90 / 04/02/2009 / 52 / Callaghan / 2308
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / University of Sydney / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Incidence and risk factors for lymphoedema secondary to breast cancer: a prospective cohort study. App570801. CA-A0809/30 / $581,916.25 / 04/02/2009 / 48 / Sydney / 2006
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / University of Sydney / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Quality of life outcomes and cost effectiveness of pelvic exenteration for people with advanced rectal cancer. App570860. CA-A0809/31 / $211,777.50 / 04/02/2009 / 71 / Sydney / 2006
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / University of Sydney / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Phase III study in patients with Locally Advanced Pancreatic cancer: Gemcitabine +/- chemoradiotherapy & +/- erlotinib. App570948. CA-A0809/34 / $284,900 / 04/02/2009 / 90 / Sydney / 2006
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / University of Sydney / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Genome-wide analysis of pre-mRNA splicing regulation by RBM4. App570874. CA-A0809/32 / $20,597.50 / 05/02/2009 / 12 / Sydney / 2006
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / University of Sydney / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Understanding the psychosocial sequelae of surviving testicular cancer. App570961. CA-A0809/35 / $104,940 / 05/02/2009 / 24 / Sydney / 2006
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / University of Sydney / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Short Course Oncology Therapy - A Study of Adjuvant Chemotherapy in Colorectal Cancer by the CACTUS and OCTO Groups. App571314. CA-A0809/38 / $329,752.50 / 05/02/2009 / 59 / Sydney / 2006
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / University of Sydney / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: The role of melanoma stem cells in melanomagenesis. App570778. CA-A0809/21 / $20,625 / 09/02/2009 / 12 / Sydney / 2006
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / University of Southern Queensland / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: A Randomized Trial of a Shorter Radiation Fractionation Schedule for the Treatment of Localized Prostate Cancer (PROFIT – Prostate Fractionated Irradiation Trial). App570403. CA-A0809/20 / $487,850 / 12/02/2009 / 36 / Toowoomba / 4350
Cancer Australia / Support for Cancer Clinical Trials Program / Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) through University of Sydney / Support for Cancer Clinical Trials Program - CA-A0809/52 / $839,905.00 / 18/02/2009 / 18 / University of Sydney, NSW / 2006
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / Walter and Eliza Hall Institute / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Role of the GATA-3 transcription factor as a tumour suppressor and potential therapeutic target in breast cancer. App575572. CA-A0809/53 / $326,803.95 / 20/02/2009 / 36 / Parkville / 3050
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / University of Adelaide / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Faecal microflora and circulating proinflammatory cytokines: key elements to chemotherapy-induced diarrhoea. App553601. CA-A0809/54 / $20,625 / 25/02/2009 / 12 / Adelaide / 5005
Cancer Australia / Improved Cancer Control / Improved Cancer Control / Cancer Institute NSW / The continuation of Cancer Service Networks National Demonstration Program (CanNET) in New South Wales / $932,091.60 / 16/03/2009 / 56 / Alexandria, NSW / 1435
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / University of NSW / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2008: Development of an optimised multidisciplinary intervention for post-cancer fatigue. App568828. CA-A0809/64 / $474,650 / 15/06/2009 / 61 / Sydney / 2052
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / University of Adelaide / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: A combinatorial approach targeting androgen signalling for treatment of prostate cancer. App627229. CA-A0910/87 / $321,028.95 / 01/01/2010 / 36 / Adelaide / 5005
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / University of South Australia / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Development of microfluidic chips to isolate and analyse peripheral blood cell populations in pancreatic cancer patients. App631921. CA-A0910/56 / $24,750 / 06/01/2010 / 12 / Adelaide / 5001
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / Ludwig Institute of Cancer Research / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Mechanisms of abiraterone resistance in prostate cancer. App603107. CA-A0910/57 / $216,150 / 18/01/2010 / 36 / Heidelberg / 3084
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / Garvan Institute of Medical Research / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Identifying and targeting Docetaxel resistance in hormone refractory prostate cancer. App596858. CA-A0910/54 / $213,950 / 20/01/2010 / 36 / Darlinghurst / 2010
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / Monash University / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: The role of the EphA3 receptor in the stromal microenvironment of tumours. App606719. CA-A0910/58 / $24,750 / 20/01/2010 / 12 / Clayton / 3168
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / Monash University / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Novel monoclonal antibodies for the diagnosis and treatment of epithelial cancers and cancer stem cells. App606552. CA-A0910/55 / $94,806.80 / 21/01/2010 / 12 / Clayton / 3168
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / University of Queensland / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: LACE – Laparoscopic Approach to Carcinoma of the Endometrium. An International Multicentre Randomised Phase 3 Clinical Trial. App631523. CA-A0910/46 / $643,775 / 27/01/2010 / 36 / Brisbane / 4072
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / University of Melbourne / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Lymphocyte receptors that regulate tumor development and therapy. App628304. CA-A0910/49 / $24,571.80 / 29/01/2010 / 12 / Parkville / 3010
Cancer Australia / Priority Driven Collaborative Cancer Research Scheme / University of Melbourne / Priority Driven Collaborative Cancer Research Scheme (PDCCRS) 2009: Preventing Breast Cancer in BRCA1 and BRCA2 Mutation Carriers: kConFab Follow-Up Project. App628333. CA-A0910/51 / $327,731.25 / 29/01/2010 / 36 / Parkville / 3010